Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables. [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating whether a single polypill can prevent cardiovascular disease in an urban population, with analysis focused on liver-related v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PolyPill (single-pill fixed-dose combination) (Fixed-dose combination of antihypertensive agents, statin, and antiplatelet components)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Cardiovascular Diseases | Phase 3 | Status: COMPLETED